The 2012 Market for Antibodies

As players in the rapidly growing antibodies market, companies both large and small are enjoying a consistent source of revenue stream in what appears to be an almost recession-proof line of products. Scientific research is yielding promising diagnostic and therapeutic uses for antibodies in the treatment of cancer, autoimmune diseases and a host of other maladies that demand a healthy share of public and private funds. Additionally, as generic companies continue to chip away at the traditionally large pipelines of big pharma, drug companies are seeking new ways to stay relevant and offer products that promote their brands. Scientific discovery is driving the market, and antibodies suppliers are acting quickly to jockey for lead positions.

The 2012 Market for Antibodies is BioInformatics LLC’s newest report, a comprehensive analysis of this lucrative market. Designed specifically for suppliers of commercial, pre-made catalog antibodies, this primary research report identifies scientists’ expectations and preferences with regards to usage, brands, purchasing, product quality and budgets. For companies competing in the antibodies market and for those about to enter, key findings highlight market share, competitive positioning, customer satisfaction and how well current products meet researchers’ needs. Additionally, the report identifies “best in class” vendors by application, most widely-used techniques and recommended new targets, all of which identify gaps that present opportunities for antibodies suppliers.

The 2012 Market for Antibodies is also a supplier’s resource for understanding the criteria laboratories use to choose their antibodies suppliers and the critical touchpoints in the purchasing process where suppliers can influence the decision. More specifically, HOW antibodies are ordered is documented, with an emphasis on typical size of purchases, average spend, projected spend, preferred ordering channels (to include online buying preferences) and likelihood to repurchase.

For suppliers that are seeking ways to differentiate their products in this competitive market, The 2012 Market for Antibodies delineates what almost 1,100 scientists from laboratories around the world indicate would help them achieve their research objectives. At strategic and tactical levels, suppliers can use this report with confidence to make decisions about developing and marketing commercial, pre-made catalog antibodies.